GlassScriptPhysician profile
Andrew C Brown
NPI 1528027646
$2,725.18
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,112 · 2020: $551 · 2021: $44.59 · 2022: $17.83.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $473.82 | 2019-2020 | |
| Glaxosmithkline, LLC. | $436.83 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $242.86 | 2019-2020 | |
| Insmed, INC. | $229.44 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.81 | 2019-2020 | |
| United Therapeutics Corporation | $182.05 | 2019-2020 | |
| Mylan Specialty L.P. | $150.18 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $122.44 | 2019 | |
| Genentech USA, INC. | $111.37 | 2019-2020 | |
| Grifols USA, LLC | $100.11 | 2019 | |
| Harmony Biosciences LLC | $84.28 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $65.58 | 2019 | |
| Genzyme Corporation | $59.78 | 2019 | |
| Jazz Pharmaceuticals INC. | $47.92 | 2019-2020 | |
| Circassia INC. | $47.26 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $30.13 | 2019 | |
| Resmed Corp | $29.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.89 | 2019 | |
| Angiodynamics, INC. | $21.36 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $20.23 | 2019 | |
| Philips North America LLC | $16.75 | 2020 | |
| Allergan, INC. | $15.27 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.